Duloxetine API Market Duloxetine API and Therapeutics Review Analysis 2027

 Market Highlights

The global duloxetine API market is expected to register a CAGR of 3.52% and is anticipated to reach USD 3,985.0 million by 2027. Active pharmaceutical ingredients (APIs) are used in the manufacturing of pharmaceutical dosage forms such as tablets and capsules. Duloxetine is a serotonin-norepinephrine reuptake inhibitor used in the treatment of depression and anxiety. Additionally, duloxetine API is used to help relieve neuropathic pain in people with diabetes or ongoing pain due to disease conditions such as arthritis, fibromyalgia, and chronic back pain.

The factors such as the rising prevalence of depression, growing penetration of generic drugs, growing cases of anxiety, the growing trend of outsourcing, strong drug pipeline, and increasing demand for newly developed small molecule drugs are expected to drive the market growth during the forecast period.

Key Players:

Market Research Future (MRFR) recognizes the following companies as the key players in the global duloxetine API market that includes Teva Pharmaceutical Industries Ltd (Israel), Sun Pharmaceutical Industries Ltd (India), Aurobindo Pharma (India), Lupin (India), Zydus Cadila (India), Eli Lilly and Company (United States), Shodhana Laboratories (India), Hetero (India), Apotex Inc. (Canada), Shionogi Inc. (US), and Zhejiang Huahai Pharmaceutical Co., Ltd (China)

Segment analysis

The global Duloxetine API Market has been segmented into application. Based on application, the market has been segmented into major depressive disorder, generalized anxiety disorder, fibromyalgia, neuropathic pain, chronic musculoskeletal pain, and others. The chronic musculoskeletal pain accounted for a market value of USD 200.0 million in 2022.

Regional Analysis

Geographically, the Americas is expected to dominate the global duloxetine API market. In this region, North America is expected to dominate the market owing to the increasing incidence of chronic diseases such as psychological disorders, diabetes, increasing government focus on generic drugs, and technological advancements in the manufacturing processes of APIs. In Europe, the market growth is majorly due to the increasing pharmaceutical sector. Additionally, in Europe, countries such as the UK, Germany, and France have a higher demand for API and thereby drive the growth of the overall market. The Asia-Pacific market for duloxetine API is considered to be growing significantly due to the rising healthcare spending and a growing number of contract manufacturing organizations (CMOs). In this region, Japan accounted for a market share of 13.7% in 2022. Moreover, the Middle East and Africa accounted for the least share of the market. The low market share is due to the limited number of companies manufacturing duloxetine API.

Key Findings of the Study:

Global duloxetine API market is projected to reach USD 3,985.0 million by 2027 with 3.52% CAGR during the review period of 2022 to 2027.

Americas accounted for the largest share in the region due to the rapidly growing prevalence of anxiety and depression.

Some of the players operating in the duloxetine API market include Lupin, Teva Pharmaceutical Limited, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma, Lupin, Zydus Cadila, among others.

This research report provides insights, on various levels of analysis such as industry analysis, market share analysis, leading market players, and their profiles. This report also helps in studying the target segments by providing views on emerging and high-growth segments and market conclusion. Together the market data comprises and discusses basic assessments on the competitive scenarios and strategies of the global duloxetine API market, including the high-growth regions and their political, economic, and technological environments. Furthermore, the project report also provides views over historical market values as well as, pricing and cost analysis of the same.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America

Pipettes, Pipettors, and Accessories Market Forecasts by Global Industry Till 2027

 Market Highlights:

The Global Pipettes, Pipettors and Accessories Market held a market value of USD 1,350.0 million in 2017 and is projected to grow at a CAGR of 4.1% over the forecast period. A pipette is a laboratory tool used in laboratories to transfer a measurable amount of liquid from one container to another. These are small tubes or slender graduated tubes of glass or plastic used in laboratories to transfer a measurable volume of liquid. A pipettor is an instrument used to dispense liquid while pipetting.

This instrument allows remote operation of a pipette, usually by the attachment of an extension tube. Factors characterizing the market growth are rising investment in research and development (R&D) activities, increasing demand for accuracy, productivity, and quality, growing focus on improving lab throughputs, and mounting applications in life sciences and biomedical research, pharmaceutical, environmental, chemical, and food processing industries. For instance, on 20 December 2018, the Cancer Institute (WIA), an Indian non-profit cancer treatment and research center launched India’s first molecular lab for cervical cancer screening. In addition, on 10 December 2018, AstraZeneca plc collaborated with Cancer Research UK to launch a center of excellence in genetic screening, cancer modelling and big data processing in order to accelerate the discovery of novel cancer medicines in the UK.

Key Players:

Some of the leading players in the Global Pipettes, Pipettors and Accessories Market are Thermo Fisher Scientific Inc., Thomas Scientific, Inc., BRAND GMBH + CO KG, CAPP ApS, Corning Incorporated, Hamilton Company, Eppendorf AG, Gilson Incorporated, Greiner Bio-One International GmbH, INTEGRA Biosciences AG, The Lab Depot, Inc., Sartorius AG, Socorex Isba S.A., Nichiryo Co.,Ltd., and Mettler-Toledo International Inc.

Segmentation:

The Global types of pipettes, Pipettors and Accessories Market has been segmented into product and end user. By product, the market has been segmented into pipettes, pipettors, and accessories. The pipettes segment is further categorized into beral/plastic/transfer/disposable pipettes, pasteur/glass pipettes/droppers, serological pipettes, volumetric/bulb pipettes, and others. The pipettors segment is sub-segmented into electronic pipettors and manual pipettors. These two pipettors are further separately categorized into single-channel pipettors and multichannel pipettors.Based on end user, the market has been segmented into hospitals, laboratories, academic & research institutes, pharmaceutical & biotechnology companies, and others.

Regional Analysis:

The Global Pipettes, Pipettors and Accessories Market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. On the basis of region, the Americas is likely to dominate the global pipettes, pipettors, and accessories market owing to the increasing biotechnology and pharmaceutical R&D activities and the presence of major market players in the U.S. and Canada. In November 2018, the US Food and Drug Administration (US FDA) emphasized on improved outcomes and R&D over the biotech industry due to the expiry of more than 25 drugs patents.Europe will hold the second largest market position during the forecast period due to the availability of developed lab facilities, the number of key market participants headquartered, and the presence of sophisticated healthcare infrastructure.

 The market in Asia-Pacific is anticipated to display comparatively higher CAGR during the forecast period owing to growing awareness and increasing interest in scientific & industrial research in order to create new business opportunities in India, China, Japan, and Australia. The Middle East & Africa has the least share of the global pipettes, pipettors, and accessories market. Additionally, the major market share of the region would be held by the Middle East region attributed to gradually rising adoption of laboratory supplies or equipment in the GCC region.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America

Protein Microarray Market Abbott Inc., Alcon Laboratories, Etc Key Players Forecasts till 2027

 Protein Microarray Market - Competitive Landscape

The Key Players in Protein Microarray Market include SEQUENOM, Inc. (U.S.), Agilent Technologies (U.S.), Illumina Inc. (U.S.), GE Healthcare (U.S.), Bio-Rad Laboratories Inc. (U.S.), Affymetrix, Inc. (U.S.), Abbott Laboratories (U.S.), Sigma Aldrich Corporation (U.S.), Cepheid Inc. (U.S.), Thermo Fisher Scientific (U.S), PerkinElmer Inc. (U.S.), Fluidigm Corporation (U.S.), Medtronic Inc. (U.S.), EMD Millipore (U.S.), Angioscore Ltd. (U.S.), and F. Hoffmann-La Roche AG (Genentech) (Switzerland).

Protein Microarray Market- Overview

Protein microarray, also known as protein chips are an emerging class of proteomic technology which is used to track the interactions and activities of proteins. They have become a major tool in molecular biology and biochemistry. The application of protein microarray is expanding gradually, and Market Research Future (MRFR) projects the global protein microarray market to post a CAGR of 8.2% over the forecast period of 2022-2027.

The key areas where Protein Microarray Market finds application include diagnostics, proteomics, protein functional analysis, antibody characterization, and treatment development. Protein microarray has proven to be a promising tool in the diagnosis of cancer. Protein microarray serves as a versatile and robust platform in cancer proteomics as it provides the advantages of sensitive detections. The elevating incidence rate of oncological diseases across the globe is likely to fuel the growth of the global protein microarray market.

Protein Microarray Market - Segmentation

The global protein microarray market has been segmented based on type, application, product, technology, and end user.

By type, the global protein microarray market has been segmented into protein chips, lab-on-chips (microfluidics), integrated systems, arrayers, and microarray systems.

By application, the global protein microarray market has been segmented into diagnostics, proteomics, protein functional analysis, and antibody characterization.

By product, the global protein microarray market has been segmented into protein microarray instruments, protein microarray reagents, and protein microarray services.

By technology, the global protein microarray market has been segmented into analytical microarrays, functional protein microarrays, and reverse phase protein microarray.

By end user, the global protein arrayer market has been segmented into hospitals, clinics, diagnostic centers, academic institutes, research centers, and others.

Protein Microarray Market - Industry Updates

In October 2022, researchers at the University of Texas have demonstrated a new protein sequencing method. The new method could have a profound impact in biomedical research and will assist to reveal new biomarkers for cancer diagnosis as well as diagnosis of other diseases.

Protein Microarray Market - Regional Analysis

The Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA) are the key markets for protein microarray. The Americas is the largest market for protein microarray. A high incidence rate of cancer, high healthcare expenditure, and increasing awareness spurs market growth in the Americas. Also, the presence of a well-developed healthcare sector and high demand for advanced treatment options boost the growth of the market.

Europe is the second largest market for protein microarray treatment, the growth of which can be attributed to extensive R&D efforts for the development of new drugs.

APAC is likely to exhibit rapid growth over the forecast period and emerge as the fastest growing market for microprotein array. Growing adoption of protein chip in emerging economies of China, India, and Japan create lucrative growth opportunities for the growth of the protein microarray market in APAC. Surging awareness regarding personalized medicine, increasing incidence of cancer, and government funding are expected to boost the market growth.

The MEA market will exhibit positive growth trend over the forecast period due to expanding healthcare sector, growing investment by market players in the region and increased adoption of protein microarrays for diagnostic purpose.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America

Isotretinoin Drugs Market Share Analysis, Strategies, Revenue and Forecasts to 2027

 Isotretinoin Drugs Market – Highlights

The global Isotretinoin drugs Market has been evaluated as steadily growing market and it is expected that the market will continue to grow similarly in the near future. Increasing prevalence of various skin disorders, genetic disorders and cancer are major driving forces for the market. Moreover, increasing R&D funding another major driving factor for the market growth.

The market for isotretinoin drugs was around US$ 1257.0 million in 2016 and is expected to reach US$ 1567.1 million which is projected to grow at a CAGR of 3.2% by 2027.

Isotretinoin Drugs Market - Major Players

There are plenty of large and small market players which operate in this market: Akorn, Inc. (US), Dr. Reddy’s Laboratories Ltd. (India), F. Hoffmann-La Roche Ltd (Switzerland), Mylan N.V. (US), Ranbaxy Laboratories Inc, a SUN PHARMA company. (India), Teva Pharmaceuticals USA, Inc (US), and others

Hoffmann-La Roche Ltd is pioneer in global Isotretinoin drugs market. Major Isotretinoin drugs manufacturers like F. Hoffmann-La Roche Ltd, Mylan N.V. and Ranbaxy Laboratories Inc. are holding major market share while other players holds reasonable amount of share in the market. North America and Europe is main focus of all major players but due to rapid growth rate in Asia-Pacific, these companies are expanding their business in this region. Isotretinoin drugs causes some serious side effects such as birth defects and depression. To avoid these kind of situation, drug manufacturers are focusing more on new drug development. Due to strict regulatory policies, all the top players are trying to improve the efficacy and safety of isotretinoin drug.

Isotretinoin Drugs Market - Segmentation

Global Oral Isotretinoin Market has been segmented on the basis of application which comprise severe acne, Neuroblastoma, Cutaneous T-Cell Lymphomas, harlequin ichthyosis, xeroderma pigmentosum, fibrodysplasia ossificans progressiva, Squamous cell skin cancers, and others. Severe acne is further sub-segmented into Nodulocystic acne, Acne conglobate, Acne fulminans, Gram negative folliculitis, and others. Neuroblastoma is further sub-segmented into Stage 1, Stage 2A, Stage 2B, Stage 3, Stage 4, Stage 4S, and others. Cutaneous T-Cell Lymphomas is further sub segmented into Mycosis fungoides, Pagetoid reticulosis, Lymphomatoid papulosis, Granulomatous slack skin, and others. Xeroderma pigmentosum is further sub-segmented into group A, group B, group C, group D, and others. On the basis of end user, the market is segmented into Hospitals, Research laboratories, and others.

Isotretinoin Drugs Market - Regional Analysis

Globally, North America is holding the largest market share in global Isotretinoin drugs due to increasing prevalence of various skin diseases. While the European region accounts the second largest market in this market. The increasing cases of various genetic disorders and cancer in Western Europe region has spurred the growth rate and it accounts largest share in European market. Due to developing healthcare sector, rising healthcare spending and increasing awareness of disorder and diseases, Asia-Pacific region will be fastest growing market for isotretinoin drugs during the forecast period. Middle East and Africa isotretinoin drugs market is expected to grow slower than global average during the forecast period.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America

Spinal Implants Market Top 7 Key Players Revenue, Share, Demand and Forecasts Till 2027

 Spinal Implants Market Overview:

Spinal implants are useful for the treatment of spinal deformities. Market Research Future (MRFR) has published a research report about the global spinal implants market that infers boost with 5.5% CAGR during the forecast period between 2022 and 2027.

Factors that are enhancing the market growth for spinal implants include the development of safer technology, innovation of cost-effective spinal devices, and increasing demand for minimally invasive spine surgery. However, some factors that can hamper the growth of the market include lack of reimbursements in developing countries, high procedural costs, and stringent regulatory guidelines for the approval of new medical devices.

Key Players:

The key players in the global Spinal Implants Companies include Accel Spine (USA), AESCULAP (USA), Alliance Spine (USA), Alphatec Holdings, Inc. (the USA), Amedica Corporation (USA), Apollo Spine (USA), Ascendx Spine (USA), A-Spine (Taiwan), Back 2 Basics Spine (Canada), Captiva Spine Inc. (USA), Centinel Spine (USA), Depuy Synthes Inc. (Johnson & Johnson) (USA), Exactech Inc. (USA), Globus Medical, Inc. (USA), Integra LifeSciences (USA), K2M Group Holdings, Inc. (the USA), LDR Holding Corporation (USA), Life Spine (USA), Medtronic, plc (Ireland), NLT Spine (USA), NuVasive, Inc. (the USA), Orthofix International N.V. (Netherlands), Paradigm Spine LLC (USA), Precision Spine (USA), Premia Spine (Israel), Quandary Medical LLC (USA), Reliance Medical Systems (USA), RTI Surgical, Inc. (USA), SI-BONE (USA), Spine Frontier (USA), Spineart Geneva SA (Switzerland), SpineGuard (France), Spinal Solutions Inc. (USA), Stryker Corporation (USA), and Zimmer Biomet Holdings, Inc. (USA).

Segmentation:

The global Spinal Implants Market has been segmented on the basis of material, procedure, product, and lastly region. Material based segmentation of this market segments the market into plastic, stainless steel, titanium, titanium alloy, and others. Based on the procedure, the market has been segmented into minimally invasive surgery (MIS), open surgery, and others.

The product-based segmentation covers spine biologics, spinal bone stimulators, spinal fusion devices, non-fusion devices/motion preservation devices, Vertebral Compression Fracture (VCF) treatment devices, and others. Spine Biologics have been sub-segmented into bone graft substitutes, cell-based matrix, and spinal allografts. The bone graft substitutes have been further segmented into bone morphogenetic proteins and synthetic bone grafts. The further segmentation of spinal allografts covers demineralized bone matrix and machined bones allograft.

The spinal bone stimulators have been sub-segmented into invasive spine bone stimulators and non-invasive spine bone stimulators. The non-invasive spine bone stimulators have been further segmented into capacitive coupling (CC) & combined magnetic field (CMF) device, and a pulsed electromagnetic field device.

The spine fusion devices segment has been sub-segmented into cervical fixation devices, interbody fusion devices, thoracolumbar devices, and others. Cervical fixation devices have been further segmented into anterior cervical plates, clamps, hook fixation systems, plates & screws, and wires. Interbody fusion devices have been further segmented into bone interbody fusion devices and non-bone interbody fusion devices. Thoracolumbar devices have been further segmented into anterior lumbar plates, crosslinks, hooks, lumbar plates, pedicle screw, and wires & cables.

Non-fusion devices/motion preservation devices have been sub-segmented into annulus repair devices, artificial discs, dynamic stabilization devices, and nuclear disc prostheses. Artificial discs have been further segmented into artificial cervical discs and artificial lumbar discs. Dynamic stabilization devices have been further segmented into facet replacement products, interspinous process spacers, and pedicle screw-based systems. VCF treatment devices have been further segmented into balloon kyphoplasty devices and vertebroplasty devices.

Regional Analysis:

The regional segmentation of the global spinal implants market has segmented the market on the basis of continents named The Americas (North America & South America), Europe, Asia Pacific, and the Middle East and Africa (MEA). The Americas dominate the global spinal implants market due to the advancement in manufacturing processes, the contribution of nanotechnology to the pharmaceutical packaging market, and technological innovation. Due to the availability of advanced technology and the best medical facilities, North America is a bigger market than South America. In this region, the most important country-specific markets are the United States of America (USA) and Canada. Many key players in the market are based in the USA. In South America, the strongest economies that can emerge as lucrative markets someday are Argentina and Brazil.

Europe is an important market because, after North America, it is the most technologically advanced market. Due to the reasons same as the Americas, Western Europe is a bigger market than Eastern Europe. In Western Europe, the most significant country based markets are France, Germany, Italy, Spain, and the United Kingdom (UK), followed by the rest of Western Europe. In Europe, the spinal implants market is growing due to due to its increasing geriatric population and the growing demand by geriatric people for the spinal implants and devices.

According to the report, Asia Pacific is an emerging market due to the rapid urbanization and the gradual increase in obesity which has led to increased spinal disorders. The most important factors that are creating the demand for spinal implants and driving the market include advanced treatments, increasing awareness with regards to spinal problems and novel spine treatment techniques, increasing healthcare expenditure, and increasing government support for advanced healthcare technologies. The primary country-specific markets in this region are Australia, China, India, Japan, and South Korea, followed by the rest of the Asia Pacific region.

In the MEA region, the market is small and limited. Reasons for the limited market growth in this region are lack of awareness, lack of education, lack of technological development, political instability and healthcare not being considered a priority by the government. In this region, the maximum revenue is generated by the country-specific markets namely Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates (UAE), followed by the rest of the MEA region.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America

EMEA Insomnia Market SWOT Analysis, Key Players, Analysis and Forecasts Till 2027

 Market Highlights

Insomnia is the most common disorder in Europe, Middle East and Africa. Large number of people suffer from insomnia in these regions. Europe, the Middle East and Africa Insomnia 2022 market is driven mainly because of increasing insomnia patients principally due to increasing workload and pressure, changing lifestyle and high incident of mental disorders which favor the growth of this market. Anxiety and depression also contribute to an increase in the market of insomnia. Increasing prevalence of neurological disorders favor the growth of the market. Emphasis on awareness and education of insomnia regarding its symptoms and causes also boost this market.

Key Players:

Pfizer Inc. (U.K), Sanofi (France), GlaxoSmithKline Plc. (UK), Astellas (UK), Biocodex S A (France), Neurim (Switzerland). Other players are Flynn Pharma (UK) CAD Middle East Pharmaceutical Industries LLC (Saudi Arabia), Tabuk Pharmaceutical (Jordan).

Segmentation:

Europe, The Middle East and Africa Insomnia Market has been segmented on the basis of types of therapy which comprises pharmacological therapy and non-pharmacological therapy. Pharmacological therapy is further segmented into benzodiazepines, non-benzodiazepines, melatonin receptor agonists and other. Nonpharmacological treatment are further segmented into relaxation therapy, cognitive behavioral therapy, sleep hygiene education, stimulus control, paradoxical intention and other. By drug formulation they are segmented as capsules, tablet and others. On the basis of type of disease they are poor quality of sleep, sleep maintenance and other.

Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including cardiology, oncology, diabetology, neurology and immunology. Indiplon is a drug manufactured by Pfizer for insomnia. Pfizer, Inc. is a US headquartered pharmaceutical company. SONATA is one of the major product of this company. Company is focusing on the development of the new sleeping pills. Company has successfully completed the phase 4 study of Pristiq for the treatment of depressive disorders.

Sanofi is a global life science company. It manufactures drugs for immunology, cardiology, diabetes, oncology and other healthcare specialties. Zolpidem is a drug manufactures by the company for insomnia. The study of effect of this drug on people with insomnia was carried by the company in 2007.

GlaxoSmithKline Plc. is a global pharmaceutical company manufacturing and marketing the products and solutions in healthcare industry.  In 2008. The company collaborated with Acetelion to conduct clinical trials on orexin receptor antagonist for insomnia. In 2011, the company stopped these trails as a safety concern as the subjects were unable to tolerate the dose of medicine.

Neurim is a drug discovery and development company. The company mainly focuses on insomnia and neurogenetic diseases to improve the quality of life of the patients. “Circadin”” was the first approved drug for insomnia.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America

Ultrasound Probe Disinfection Market to Be Driven by Rising Instances of Diseases Outlook by 2027

 Market Highlights

The Ultrasound Probe Disinfection Market is expected to witness tremendous growth owing to the rising demand for disinfectant probes in hospitals, increasing cases of bacterial infection in healthcare center during the treatment, and increasing implementation of high-level disinfection process for critical ultrasound probes. The global ultrasound probe disinfection market was estimated USD 314.1 million in 2022 and expected to reach USD 819.1 million by 2027 at a healthy CAGR of 21.1% by 2027.

However, factors such as high cost of switching, maintenance cost for the ultrasonic instrument may hinder the market growth during the forecast period.

Key Players

Some of the key players in the global ultrasound probe disinfection market are STERIS (UK), Nanosonics (Australia), Tristel (UK), Ecolab (US), Schülke & Mayr (Germany), Advanced Sterilization Products (US), CIVCO Medical Solutions (US), Germitec (France), Parker Laboratories (US), CS Medical (US), Virox Technologies (Canada), and Metrex Research (US).

Segmentation

The Global Ultrasound Probe Disinfection Market is segmented on the basis of product, probe type, by process and end-user. The ultrasound probe disinfection market, by product, is segmented into instrument, service, and consumables. The instrument is segmented into automated probe reprocessors, UV-C disinfectors, manual reprocessors/soaking stations, and ultrasound transducer storage cabinets. The consumables are sub-segmented into formulation, type of disinfectants, and detergents. The disinfectants, by formulation, is segmented into disinfectant wipes, disinfectant liquids, and disinfectant sprays. By type, consumables are segmented into high-level disinfectants, and intermediate/low-level disinfectants and detergents are segmented into enzymatic detergents and non-enzymatic detergents.

By probe type the market is segmented into linear transducers, convex transducers, phased array transducers, end cavitary transducers, transoesophageal echocardiography transducers| (TEE), and other. On the basis of process, the market is segmented into high-level disinfection and intermediate/low-level disinfection. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centres, ambulatory care centers, academic & research institutes, and others.

Regional Analysis

The Americas leads in the ultrasound probe disinfection systems market owing to the increasing prevalence of rising incidence of bacterial infection, increasing research & development in ultrasound probe disinfection and growing healthcare expenditure. According to the Consumer Report Organization and Centers for Disease Control and Prevention (CDC)  July 2015 publication, it is estimated that every year approximately 648,000 patients in the US got infected by bacteria during a hospital stay, and around 75,000 died. The increasing incidences of bacterial infection may support this market positively.

Europe is the second largest ultrasound probe disinfection market during the forecast period due to increasing prevalence of human papillomavirus (HPV). The human papillomavirus is a skin to skin transmitted disease. According to the Oxford Vaccine group fact sheet, HPV infection causes cervical cancers. It was also reported that 99% of cervical cancers are caused by the Human Papillomavirus (HPV) infection. Furthermore, it was also maintained that 3,126 new cases of cervical cancer were reported in the UK in 2015. The increasing prevalence of HPV infection supports the market growth in this region.

Asia-Pacific was estimated to be the fastest growing region for the global ultrasound probe disinfection market in 2017. The market is expected to witness high growth owing to the rising prevalence of bacterial infections. The Middle East and Africa holds the low share for this market. However, the rising healthcare awareness at the hospital and in the community are expected to influence the market positively.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America